Drug search by name

Boceprevir and Pancytopenia

Result of checking the interaction of drug Boceprevir and disease Pancytopenia for safety when used together.

Check result:

Boceprevir <> Pancytopenia

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

Anemia, neutropenia and thrombocytopenia has been reported with the use of boceprevir. Boceprevir is always administered with peginterferon alfa and ribavirin which are also associated with pancytopenia. The addition of boceprevir has shown an additional decrease in hemoglobin and blood cell counts. Caution should be used in patients with preexisting anemia, neutropenia or thrombocytopenia. A complete blood count should be obtained pretreatment, and then during treatment at weeks 2, 4, 8, and 12. Patients should be monitored closely. Refer to the prescribing information for peginterferon alfa and ribavirin for additional information regarding dose reduction or discontinuation based on laboratory parameters. If ribavirin and peginterferon alfa need to be discontinued, boceprevir should be discontinued as well.

Boceprevir

Generic Name: boceprevir

Brand Name: Victrelis

Synonyms: Boceprevir (Oral)

What is Boceprevir?